Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
Cochrane
Abstract
Background:
Kaposi’s sarcoma remains the most common cancer in Sub-Saharan Africa and the second most common cancer in HIV-infected
patients worldwide. Since the introduction of highly active antiretroviral therapy (HAART), there has been a decline in its incidence.
However, Kaposi’s sarcoma continues to be diagnosed in HIV-infected patients.
Objectives:
To assess the added advantage of chemotherapy plusHAART compared toHAART alone; and the advantages of different chemotherapy
regimens in HAART and HAART naive HIV infected adults with severe or progressive Kaposi’s sarcoma.
Description
CITATION: Gbabe, O. F. et al. 2014. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews, 9: CD003256, doi:10.1002/14651858.CD003256.pub2.
The original publication is available at https://www.cochranelibrary.com
The original publication is available at https://www.cochranelibrary.com
Keywords
Kaposi's sarcoma -- Treatment, HIV infections
Citation
Gbabe, O. F. et al. 2014. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews, 9: CD003256, doi:10.1002/14651858.CD003256.pub2.